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A fter years of increases, funding for HIV/AIDS from U.S.-based philanthropies was 5% lower in 2009 compared to 2008, with disbursements falling from $618 million to $585 million  (a decrease of $33 million). This is the first year since FCAA began tracking disbursements 
(in 2005) that funding decreased. Commitments (funding budgeted to be spent in a given year but 
not necessarily disbursed in that year) also decreased, dropping by 12% between 2008 and 2009.
Disbursements by the Bill & Melinda Gates Foundation represented 57% of all philanthropic  
HIV/AIDS giving in 2009, thus any change in their funding has a great effect on the overall total. 
Disbursements from the Bill & Melinda Gates Foundation for HIV/AIDS decreased to $334 million 
in 2009, from $378 million in 2008. Disbursements from all other funders actually increased from 
$237 million to $252 million (or 5%) from 2008 to 2009.
In the wake of the recent economic recession, flat or declining global and domestic government 
funding, and a growing need on the ground, any decrease is cause for concern. A recent report 
from UNAIDS and The Henry J. Kaiser Family Foundation found that funding for the global 
epidemic from donor country governments was essentially flat between 2008 to 2009, in contrast 
to prior increases in year-to-year funding since at least 2003.1 Similarly, the decrease found in 
HIV/AIDS funding from the philanthropic sector between 2008 to 2009 also contrasts with the 
previous five years of year-to-year increases, and will need to be monitored closely to assess how it 
affects the HIV/AIDS response.
Key overall findings and highlights for 2009 include:
• Total disbursements (funding expended) from U.S.-based philanthropies decreased from $618 
million to $585 million (or 5%) from 2008 to 2009. Total commitments (funding budgeted to be 
spent) also decreased, from $417 million to $367 million (or 12%).
• This decrease departs from prior year trends in which funding increased steadily since 2005, 
reaching its peak in 2008. Compared to 2005, disbursements by U.S.-based philanthropies were 
81% higher in 2009 for all funders (from $293 million in 2005 to $532 million in 2009). However, 
over this five-year period, disbursements peaked in 2008 at $570 million.2
• Funding for HIV/AIDS from the philanthropic sector is highly concentrated among a relatively 
small number of funders, with the top 10 funders accounting for 83% of all HIV/AIDS-related 
disbursements in 2009. The Bill & Melinda Gates Foundation alone accounts for 57% of  
all disbursements.
• Corporate funders represented 18% ($106 million) of total 2009 disbursements (a slight 
increase from 16%, or $100 million, in 2008) and 45% of all HIV/AIDS-related philanthropic 
funding from funders other than the Bill & Melinda Gates Foundation. 
1 UnaidS and the henry J. Kaiser Family Foundation. Financing the Response to AIDS in Low- and Middle-Income 
Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009. July 
2010. available at: www.kff.org/hivaids/upload/7347-06.pdf
2 For funders for which five years of funding data (2005–2009) are available. (these funders’ 2009 total represents 
89% of all funding in 2009.)
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Key findings on funding for international initiatives include:
• Most HIV/AIDS funding provided by U.S.-based philanthropies in 2009 (81% of disbursements) 
was directed to addressing the epidemic outside of the United States. Even without the Bill 
& Melinda Gates Foundation, which exclusively funds HIV/AIDS projects outside the U.S., 
the majority of funding (55%) by all other top funders was directed outside the United States. 
However, funding for international initiatives did decrease between 2008 and 2009 by $48 
million, or 9%.
• A majority of funders (61% in 2009) devoted some or all of their giving to addressing the 
international epidemic. Almost a quarter (23%) of funders provided funding exclusively for the 
international epidemic, although this is down from 2008 (32%).
• There were slight increases in funding provided to multilateral organizations including the 
World Health Organization (WHO) and other parts of the UN system, as well as in the Western 
and Central European region, from 2008 to 2009. Lesser amounts of funding were disbursed 
to Eastern and Southern Africa in 2009 compared with 2008 ($190 million in 2008 and $158 
million in 2009); South Asia and the Pacific ($82 million in 2008 and $50 million in 2009); as 
well as Latin America ($16 million in 2008 and $12 million in 2009) and the Caribbean ($4 
million in 2008 and $2 million in 2009). Funding to the Eastern Europe and Central Asia region 
also decreased, from $19 million in 2008 to $12 million in 2009, though it is considered the 
fastest-growing epidemic in the world, largely driven by injecting drug use.
• The biggest share of international funding went to research in 2009 ($151 million, or 32% of 
all international funding), followed by prevention ($132 million, or 28%) and treatment ($74 
million, or 16%). Compared with 2008, only funding for prevention increased by 18% (from 
$112 million to $132 million); funding for all other international intended use categories 
decreased from 2008 to 2009. Among funders other than the Bill & Melinda Gates Foundation, 
funding decreased to treatment (from $40 million to $26 million), research, social services and 
human resources, but increased to advocacy (from $20 million to $23 million) and to orphans 
and vulnerable children. 
Key findings on funding for domestic U.S. initiatives include:
• Funding provided for the domestic epidemic rose slightly (from 16% of funding in 2008 to 19% 
in 2009), and a growing share of funders provided funding exclusively to address domestic 
HIV/AIDS in 2009 compared to 2008 (39% and 34%, respectively). 
• As in previous years, the Northeast region of the United States received the largest share of 
domestic funding (47%) in 2009, a total of $54 million compared with $40 million the  
previous year. As of 2008, the region with the highest number of people living with HIV  
and AIDS was the South, which received 21% (or $23 million) of U.S. domestic philanthropic 
HIV/AIDS funding.
• The biggest share of domestic funding went to research in 2009 ($34 million), followed by  
HIV prevention ($23 million) and social services ($21 million). Funding to support domestic-
based research more than doubled from 2008 to 2009. However, funding for domestic 
treatment initiatives fell 31% from 2008 to 2009 (from $21 million to $14 million), and funding 
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for domestic prevention programs declined by 15% from 2008 to 2009 (from $27 million to  
$23 million). These reductions are particularly threatening at a time when state funding  
for treatment and prevention programs has been slashed or eliminated since the economic 
crisis began.
Looking ahead, projections for 2010 suggest that total HIV/AIDS-related philanthropy funding 
levels will likely continue to decrease: 33% of the funders that answered this question forecast 
anticipated decreases for 2010, including the top funder, the Bill & Melinda Gates Foundation, 
which represented over half of all disbursements in 2009.3 Thirty-eight percent of funders expect 
their HIV/AIDS-related disbursements to remain approximately the same or are unsure about 
2010 funding levels, while 29% of funders expect their funding to increase in 2010.  
3 a large portion of the expected decrease in hiV/aidS disbursements from the bill & Melinda Gates Foundation in 
2010 will be a result of their procedure of disbursing both 2009 and 2010 commitments to the Global Fund in 2009.  
See page 36 for more detail about the bill & Melinda Gates Foundation’s contribution to the Global Fund in 2009.
• More than 33 million people are currently  
 living with HIV around the world.
• Approximately 60% percent do not know 
 they are infected.
• Over ten million people currently in need  
 of treatment do not have it.
• More than 1 million people in the United 
 States are currently living with HIV.
• At least 20% of them do not know they  
 are infected.
• In the United States alone, there are 
 56,000 new HIV infections each year.
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With few exceptions, no country escaped the global economic downturn that persisted throughout 2009. Most donor country governments and governments of low- or middle-income countries were unable or unwilling to increase funding support for 
health, including HIV/AIDS—and many went even further to announce reductions in funding 
in comparison with previous years. A report from UNAIDS and The Henry J. Kaiser Family 
Foundation found that funding for the global epidemic from donor country governments totaled 
$7.6 billion in 2009, essentially flat from $7.7 billion in 2008, and in direct contrast to the trend of 
double-digit percentage increases in funding in previous years since at least 2003.4 
The HIV/AIDS funding crisis was the main theme and challenge discussed at the XVIII 
International AIDS Conference in Vienna, Austria in July 2010. The severity of the problem 
was such that it eclipsed some important good news, including a decline in new infections 
among youth (reported by UNAIDS); further evidence confirming the preventive impact of male 
circumcision and early access to antiretroviral treatment; and the release of the findings of the first 
scientific study showing statistically significant effectiveness of a vaginal microbicide.
The pull back in financial support thus represents a major challenge to advocates, service 
providers and patients in every country. The gap between the UNAIDS estimate of what was 
needed to respond to the global HIV/AIDS epidemic and what was available widened—to 
approximately $7.7 billion in 2009, up from $6.5 billion in 2008, and is expected to reach $10 
billion by 2010.5, 6 The health and survival of millions of people living with and vulnerable to  
HIV/AIDS depends on closing this funding gap. 
The rapid and unprecedented increase in funding earlier in the decade supported the scale up 
of access to treatment and prevention services, thereby saving and prolonging millions of lives; 
reversing years of declines in average life expectancy in many nations; mitigating the debilitating 
effects of HIV-related stigma and discrimination; and instilling hope and vigor in individuals and 
communities that had long despaired. There is never a good time to reduce funding for health, 
but it is particularly disheartening when it occurs after millions in need have had their hopes and 
expectations raised.
The situation is increasingly dire for many even in the United States, the world’s richest country 
and one in which HIV prevalence is relatively low among the general population. Some 56,000 
people are newly infected with HIV every year, and high unemployment levels have forced 
more individuals to seek government-subsidized treatment and services, which are becoming 
increasingly unavailable. Though federal funding for the domestic epidemic was 4.3% higher in 
4 UnaidS and the henry J. Kaiser Family Foundation. Financing the Response to AIDS in Low- and Middle-Income 
Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009. July 
2010. available at: www.kff.org/hivaids/upload/7347-06.pdf
5 ibid.
6 UnaidS. MDG6: Six things you need to know about the AIDS response today. 2010. available at: http://data.unaids.
org/pub/report/2010/20100917_mdg6_report_en.pdf
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the 2009 fiscal year than the previous year,7 the rise was not sufficient to counter the effects of 
many states’ fiscal crises and to meet increased demand for treatment and care. 
The National Alliance of State and Territorial AIDS Directors (NASTAD) has reported that 
state budget cuts for HIV/AIDS programs and services topped $170 million nationwide in 
2009, and additional cuts are expected in many 2010 budgets. The 2009 gap alone exceeds the 
total philanthropic funds provided to U.S. domestic HIV/AIDS in 2009 by 34%. Cutbacks were 
reported in more than a third of all state AIDS Drug Assistance Programs (ADAPs) in 2009.8 The 
main impact has been that some HIV-positive people in need of antiretroviral medicines cannot 
obtain them through government programs: as of September 2010, more than 3,500 PLWHA in 11 
states were on waiting lists for medication assistance, and many other states have implemented 
other cost-containment strategies9. Though the Obama Administration promised $25 million as 
emergency funding for ADAP, this will likely only partially offset the effects of state-level budget 
shortfalls. As is often the case, lower-income individuals suffer disproportionately as access to 
medicines shrivels and other key services, such as community outreach programs, are disbanded 
or radically defunded.
With the passage of national health care reform under the Affordable Care Act, which, among 
other things, will provide expanded coverage to millions of Americans including PLWHA, and the 
release of a long-awaited National HIV/AIDS Strategy (NHAS)10 by the Obama Administration 
outlining specific goals and commitments to address the U.S. epidemic, important milestones have 
been reached. One key commitment in the NHAS is to reduce domestic U.S. HIV infections by 25% 
in five years, and the plan focuses on three main approaches to achieve that goal: reducing HIV 
incidence, increasing access to care, and reducing HIV-related health disparities. 
The Office of National AIDS Policy (ONAP) has stressed that collaboration across sectors is 
essential to achieving the outlined goals of the NHAS, and in May of 2010, invited leading 
members of the business, philanthropy and HIV/AIDS service and advocacy communities to 
the White House to discuss the role of public-private partnerships in addressing the domestic 
HIV/AIDS epidemic, as well as to highlight innovative programs currently funded by the private 
sector that align with the goals of the NHAS. ONAP has also invited members of these sectors - 
including private philanthropy - to serve on a committee to monitor the progress on the strategy’s 
implementation. However, despite these new opportunities for philanthropic leadership defined 
within the NHAS, private funders alone cannot close the gap between available resources and 
need unless the recent cutbacks at state and community levels are reversed. The additional 
7 the henry J. Kaiser Family Foundation. U.S. Federal Funding for HIV/AIDS: The FY 2009 Budget Request. april 2008. 
available at: www.kff.org/hivaids/upload/7029-041.pdf
8 national alliance of State and territorial aidS directors (naStad). Final Report on FY 2009 State Budget Cuts. 
april 2010. available at: www.nastad.org/docs/Public/inFocus/2010415_Final%202009%20naStad%20State%20
budget%20cuts%20report%20March%202010.pdf
9 national alliance of State and territorial aidS directors (naStad). ADAP Watch Update. September 2010. available 
at: www.nastad.org/docs/Public/inFocus/201097_adaP%20Watch%20update%20-%209.7.10.pdf
10 available at: www.aids.gov/federal-resources/policies/national-hiv-aids-strategy/
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investment required to achieve all of the current stated objectives of the NHAS over the next 5 
years is estimated at approximately $15.175 billion.11 Health care reform expansion will not go into 
action until 2014, and ADAP and other services for low-income PLWHA will likely need further 
emergency funding in the meantime. 
In terms of external aid, the Administration has also released more details about the new Global 
Health Initiative (GHI), an umbrella structure that incorporates all funding for global HIV/AIDS 
as well as other U.S. global health programs including TB, malaria, maternal and child health, 
and nutrition. The aim of GHI is to take a broader and more integrated approach to health by 
improving coordination and harmonization across domestic government agencies as well as 
partner organizations and recipient governments. The Administration proposed $63 billion for 
the GHI over six years,12 with an estimated $51 billion of that for PEPFAR, including HIV/AIDS, 
the Global Fund, and TB, as well as malaria. The impact of the GHI consolidation is not yet clear, 
however, and in fiscal year 2010, funding for PEPFAR did not increase as much as it did year-
to-year between 2006 and 2009. Given that the U.S. government is the world’s largest donor to 
the HIV/AIDS response, providing nearly 60% of total government donor funding in 2009, any 
changes in funding patterns have dramatic consequences.
For the Global Fund, the U.S. government recently committed $4 billion over the next three 
years, which represents a 38% increase from its previous contribution and is a larger percentage 
increase than any other donor government that pledged (though it remains to be appropriated). 
Despite this essential commitment from the U.S., its largest funder, the Global Fund currently faces 
desperate underfunding. In total, donor governments from 40 countries pledged $11.7 billion for 
the next three years, not reaching even the $13 billion “austerity” target the Fund needs to keep 
treatment levels at their current rates. As a result, targets set for enrolling several million more 
people on antiretroviral drugs by 2013 will likely have to be lowered, while 10 million people 
already currently in need are not receiving lifesaving treatment. 
Recent funding decline can also be observed in the wider world of philanthropy. A 2010 report 
from the Foundation Center revealed that among 75,000 foundations tracked, total funding in 
2009 was 8.4% lower than in 2008, the largest year-to-year decrease on record.13 Moreover, the 
foundations tracked forecasted that their funding would remain flat in 2010. While the Foundation 
Center’s report covered all funding priorities, the trend also holds true for HIV-specific funding. 
Not surprisingly, according to the Chronicle of Philanthropy, overall charitable donations in the U.S. 
(including individual fundraising and giving to United Ways) dropped by 11% in 2009—the biggest 
decrease on record in two decades.
11 holtgrave, david r. “on the epidemiologic and economic importance of the national aidS Strategy for the United 
States.” JAIDS Journal of Acquired Immune Deficiency Syndromes. 11 august 2010. Published ahead of print as PdF at: 
http://journals.lww.com/jaids/abstract/publishahead/the_Prevalence_and_clinical_course_of.99049.aspx
12 USaid press release.  “U.S. Government Support for Global health efforts.” June 18, 2010. available at: www.
globalhealth.gov/news/news/06182010.html
13 Foundation center. Foundation Growth and Giving Estimates, 2010 Edition. available at: http://foundationcenter.org/
gainknowledge/research/pdf/fgge10.pdf
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As the largest philanthropic funder for HIV/AIDS, the Bill & Melinda Gates Foundation exerts  
a singular influence, representing more than half of all disbursements in 2009. While their  
HIV/AIDS funding was 12% lower in 2009 than 2008, the Bill & Melinda Gates Foundation is 
expected to continue to play an unparalleled role in fighting the pandemic. Yet this year’s data 
emphasize the urgent need to grow the field of HIV/AIDS philanthropy by engaging new and 
renewed grantmakers in its effort. The total number of top funders—those giving $300,000 and 
above to HIV/AIDS—has decreased by 15 organizations since 2007, and with the top 10 funders 
accounting for 83% of total disbursements in 2009, even minor shifts by these leading funders can 
have an enormous effect on the sector at large. 
The narrowing numbers of names in Table 1 reflect a trend that has been occurring in the past 
several years, with funders such as the Rockefeller Foundation and the Doris Duke Charitable 
Foundation moving away from HIV/AIDS-specific funding to focus on global health systems. 
Another notable shift will be from the Ford Foundation—currently the second largest HIV/AIDS 
funder—who ended its Global HIV/AIDS Initiative in September 2010, a five-year pilot that 
resulted in funding of more than $22 million in international HIV/AIDS-related disbursements  
in 2009 alone. 
Given the field’s vulnerability, it is encouraging that this year’s report also announces the welcome 
addition of a new top 10 funder—The Phillip T. and Susan M. Ragon Institute Foundation, which 
has promised $100 million over the next ten years to create an institute dedicated to AIDS vaccine 
research, and made an initial grant of $18 million in 2009.
It is also highly encouraging that funders other than the Bill & Melinda Gates Foundation increased 
disbursements by approximately 5% in 2009 compared with 2008. Though HIV/AIDS-related 
private philanthropy in the United States and Europe represents less than a tenth of the total 
international assistance to address the HIV/AIDS epidemic at this time14, the funds reported 
herein are critical to preventing HIV infection and to saving and improving the lives of those 
affected by HIV/AIDS. The commitment of these profiled organizations underscores the 
importance of HIV/AIDS funders continuing to exercise leadership and identifying potential  
new sources of funds and strategies that will allow them to adapt to the demands and limitations 
of this epidemic. 
In our current year, there has been increased evidence of HIV/AIDS funders working in 
collaboration to address populations most in need. For example, a monumental new public-
private partnership model, the Obama Administration’s Social Innovation Fund15, awarded a $3.6 
million dollar grant to the National AIDS Fund to expand its Access-to-Care (A2C) Initiative for 
PLWHA in July 2010. This innovative grant was one of 11 total grants and one of three awarded 
by the Social Innovation Fund in the “healthy futures” area – and the only specific to HIV/AIDS, 
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representing the “single largest award for HIV/AIDS made in decades by the federal government 
from new money and non-AIDS-specific funds.”16 
The National AIDS Fund’s A2C Initiative was launched with new funding from partners Bristol-
Myers Squibb and the Walmart Foundation to increase the access and consistent utilization of 
effective HIV healthcare by PLWHA, particularly those living in poverty, who know their status 
but are not receiving HIV-specific care or support. As the Social Innovation Fund requires a 3:1 
public-private funding match, all grantees will be required to provide a local 1:1 dollar match 
toward their grant awards, providing an exciting new opportunity for public and private funders 
to partner on increasing access-to-care at the community level, one of the goals set in the National 
HIV/AIDS Strategy. 
FCAA provides an array of forums for best practice sharing and offers the following collected 
wisdom to assist funders in maximizing their impact in this challenging environment:
• Increase funding to HIV/AIDS. The bottom line is that the AIDS response needs more 
resources to save lives and rejuvenate efforts to halt the epidemic, both domestically (in the 
United States) and abroad.
• Use tools and approaches beyond writing checks:
 • Identify and maximize power to influence policymakers, other funders, media and  
 the public
 • Create and sustain partnerships and coalitions to increase leveraging power and  
 to share resources
• Build capacity and sustainability by funding general or core support, leadership 
development, technical assistance, and advocacy initiatives that strengthen direct community-
level participation in shaping policies. 
• Support human rights-based approaches. Private philanthropy must work to ensure access 
to members of marginalized and vulnerable populations that many governments and donors 
ignore or refuse to support (e.g., MSM, IDUs, sex workers, transgendered people,  
and migrants).
• Integrate programs. Approaches are needed that consider the interdependent aspects of 
health care, and unite them under fewer yet more comprehensive, coordinated programs. 
• Make clear and precise commitments and implementation plans, and be accountable  
to them. 
• Evaluate programs and adapt to a changing epidemic or context. The HIV epidemic is 
widely varied in different settings and is also constantly changing. It is therefore critical to 
evaluate programs regularly to ensure that they are reaching those most at need, and in the 
most effective and comprehensive ways possible.  
16 Visit www.aidsfund.org/2010/07/22/national-aids-fund-receives-36-million-social-innovation-fund-award-from-
corporation-for-national-and-community-service-for-access-to-care-initiative/ to read more about this project.
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• Be efficient. Make the best use of the resources available and focus on the most  
effective interventions. 
• Build from successes and prioritize evidence-based interventions. Money cannot afford 
to wasted; programs should be evidence-based and proven to work (e.g., harm reduction 
initiatives to reduce HIV transmission risk among IDUs).
• Share best practices, product information, and other resources—and do so widely  
and transparently. 
• Rise to the challenge. This can be done, and better. Let’s remain optimistic and committed to 
improving the response to HIV/AIDS.
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About FCAA
Founded in 1987, Funders Concerned About AIDS (FCAA) is the only U.S.-based organization 
comprised of and for private philanthropic institutions concerned about, engaged in or 
potentially active in the fight against HIV/AIDS. Our mission is to mobilize the leadership, ideas, 
and resources of U.S.-based funders to eradicate the HIV/AIDS pandemic—domestically and 
internationally—and to address its social and economic consequences. 
Early in 2009 the board of FCAA gathered to undertake a strategic assessment of the role of FCAA 
amidst the ever-changing landscape of HIV/AIDS and the new economy. This process led to a 
recommitment to ensuring that FCAA was prepared to play the essential role of convening and 
informing the U.S. philanthropic response to HIV/AIDS in hopes of fostering collaboration in a 
time of diminishing resources. After the successful conclusion of our inaugural annual gathering 
in September 2009, we forged a new programming approach and 2010 work plan in response to 
funder priorities:
• Monitoring, reporting on and convening funders around the development of key initiatives 
affecting HIV-related efforts, such as: the Obama Administration’s Global Health Initiative, the 
development and implementation of the National HIV/AIDS Strategy and healthcare reform. 
• A special focus on understanding and communicating the impact of state and local budget cuts 
on the work of AIDS Service Organizations around the country—and to spotlight geographies 
and populations at-risk, such as Oakland, CA. Read more about these efforts on page 28–29.
• Building bridges between HIV/AIDS and reproductive health funders by partnering with our 
affinity group colleagues at the Funders Network on Population, Reproductive Health and Rights, 
to explore issues at the intersection of our mutual networks’ focus on HIV-positive women.
• Developing connections between US, EU and global funders. This publication is the 
result of a now five-year collaboration between FCAA, our sister organization the European 
Foundation Centre’s European HIV/AIDS Funders Group (EFG), and UNAIDS to harmonize 
our collective approaches to resource tracking and to present the most accurate possible 
picture of global HIV/AIDS-related institutional philanthropy.  Further yet, FCAA and EFG 
brought together more than 200 private and public grantmakers from across the United States 
and Europe in an effort to increase networking, find commonalities and explore ways of 
working together to address HIV/AIDS more effectively. Read more on page 18.
• Providing a platform to support and coordinate efforts for domestic HIV/AIDS advocacy 
through our newly formed Domestic Advocacy Working Group. Co-chaired by AIDS 
Foundation of Chicago and the John M. Lloyd Foundation, this group of more than 20 leading 
domestic HIV/AIDS grantmaking institutions is exploring opportunities to convene partners 
in the philanthropic and advocacy communities to shine a light on urgent gaps within domestic 
AIDS advocacy that merit additional private support.
• And finally, on December 6th, 2010, FCAA will convene a special gathering in Washington 
D.C.—the 2010 AIDS Philanthropy Summit—to offer our constituents the opportunity to once 
again meet face-to-face with their peers, review the work, issues and news that shaped 2010, 
and together chart the course of FCAA’s programming for 2011.
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FCAA is dedicated to the idea that wherever and whenever possible, our work should be 
conducted in strategic partnerships in order to expand our reach and impact. Our most essential 
partnership remains that with the more than 1,500 grantmaking institutions that comprise our 
constituency. Their impact is reflected in this report, both in dollars, and in the examples of 
innovation profiled throughout, from an institution recently honored for their human rights-
based approach to grantmaking, to a new initiative working to integrate and evaluate HIV/AIDS 
prevention and family planning services together in Africa. We thank all the organizations that 
participated in this and previous year reports. Your important contribution not only makes this 
publication possible, but also makes the important political statement that HIV/AIDS-focused 
philanthropic funding is necessary and essential to ending this pandemic.  
About This Report
This is FCAA’s eighth annual publication providing data and analysis on HIV/AIDS-related 
philanthropic giving by U.S.-based philanthropic institutions, including private, family, and 
community foundations; public charities; and corporate grantmaking programs. This edition 
covers funding disbursements made in 2009. All information in this report is accurate and  
current as of September 2010. This year’s Top U.S.-Based HIV/AIDS Funders list includes 67 U.S. 
HIV/AIDS philanthropic entities, each of which disbursed $300,000 or more to HIV/AIDS in 
2009. Where possible, FCAA has observed trends in grantmaking among these top funders.
A Few Notes: 
• Some funders receive substantial funding from government sources to implement HIV/AIDS 
programming or distribute funds to other programs. While such public/private partnerships 
are undeniably valuable in ensuring that funds are allocated effectively, government funds 
(which are tracked and reported by Kaiser Family Foundation and UNAIDS) are not included 
in total grantmaking reported here because this report focuses exclusively on private  
sector philanthropy. 
• As noted in Table 1, some funders reported that they received financial resources from other 
funders tracked by FCAA. At least some of these funds were used to support HIV/AIDS-related 
funding to other institutions. In order to avoid double-counting, the top grantmakers’ total in 
Table 1 reflects a reduction of $14,955,747 to correct for reported re-granting of funds from one 
FCAA-tracked top grantmaker to another. 
FCAA’s resource-tracking work is intended to contribute to a critical and thoughtful assessment 
of the total U.S.-based philanthropic investment in HIV/AIDS. By building upon HIV/AIDS 
grantmaking information reported by the Foundation Center and Foundation Search, and 
collecting other types of detailed data directly from the HIV/AIDS funders, FCAA’s goal is to 
create an easy-to-use, comprehensive, and informative publication that captures the scope and 
depth of philanthropic funding and support for HIV/AIDS.  
We hope that this report will enable a wide range of readers to gain new understanding about  
the overall distribution and diversity of U.S. HIV/AIDS philanthropic funding as well as trends in 
this grantmaking. FCAA welcomes input from readers about how to make future editions of  
U.S. Philanthropic Support more useful. 
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FCAA identified 342 U.S.-based funders that made HIV/AIDS-related grant disbursements in 
2009. Combined, these funders supported some 5,500 HIV/AIDS-related grants or projects, 
disbursing a total of approximately $585 million to these projects.  
Note on missing data: 
The majority of private philanthropic funding for HIV/AIDS in 2009 has been captured in the 
available data. However, it is important to note that despite repeated efforts, FCAA was unable 
to obtain data from some funders, and their disbursements are therefore not included in the 
report. No data were received from the Children’s Investment Fund Foundation (US), which was 
a top funder in 2005, 2006, and 2007; Gilead Sciences, which was a top funder in 2005; and the 
Firelight Foundation, which was a top funder each year from 2005 through 2008. In addition, 
several other funders that have appeared in previous reports are not included this year for various 
reasons. They include the International Fund for Health & Family Planning—which closed in 
2009, donating all remaining funds to DKT International, a family planning organization whose 
HIV/AIDS prevention work could not be disaggregated for this report—and The Henry J. Kaiser 
Family Foundation,17 an operating foundation that develops and runs its own policy research and 
communications programs, which are increasingly difficult to value financially. 
FCAA surveyed funders about funding commitments and disbursements in 2009. Tracking 
commitments (funding budgeted for grants/projects in a given year, whether or not the funds 
were disbursed in that year) helps to gauge current and future outlays. Tracking disbursements 
(funding actually made available in a given year, which may include funding from prior year 
commitments) provides data on funds actually paid out in a given year. For some funders, 
commitments and disbursements are the same in a given year; for others, commitments indicate 
funding above or below actual disbursements in a year. 
Total disbursements in 2009 decreased from $570 million in 2008 to $532 million in 2009, or  
7%, among funders for which five years of data were available. 
Among the top funders18 tracked by FCAA for which both 2008 and 2009 disbursements data are 
available, the total value of disbursements also decreased 7% from 2008 to 2009.
17 the henry J. Kaiser Family Foundation is a private operating foundation with hiV-related activities that are 
increasingly integrated throughout its programs across the entire foundation. though the foundation is usually one of 
the top 10 funders in terms of highest annual disbursements, it is no longer possible to separately identify and report the 
level of foundation resources dedicated specifically to hiV/aidS. it should be noted that the foundation has maintained 
its commitment and level of resources dedicated to hiV/aidS both domestically and globally. (See the appendix for 
additional information about operating foundations and Kaiser’s contributions.)
18 “top funders” are those identified by Fcaa that have disbursed $300,000 or more to hiV/aidS grants and projects 
in a given year.  in 2009, a total of 67 funders met that criterion.
16 FUnderS concerned aboUt aidS
Chart 1:
Total HIV/AIDS Grantmaking Disbursements by U.S. Philanthropies 2005–200919
19 this chart includes only the funders for which Fcaa has all five years of disbursement data (2005, 2006, 2007,  
2008 and 2009) for 2005-2009: a total of 61 of 342 funders.  these same 61 funders represented 89% of all funding in 














hiv/aidS disbursements (in $ millions)
total U.S. hiv/aidS GrantmakinG in 2009
all funders
Funders other than the bill & melinda Gates Foundation
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total U.S. hiv/aidS GrantmakinG in 2009
Total commitments in 2009 among all funders were approximately $367 million, down from  
$417 million in 2008, a decrease of 12%.
Among the top funders tracked by FCAA for which both 2008 and 2009 commitments data are 
available, the total value of commitments was 17% lower in 2009, from $399 million in 2008 to 
$332 million in 2009. 
Chart 2:
Total HIV/AIDS Grantmaking Commitments by U.S. Philanthropies 2000–200920, 21
20 this chart includes all commitments data available for all top funders each year.
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the Ford Foundation’s new initiative to address 
the domestic U.S. hiV/aidS epidemic; supporting 
prevention of vertical transmission initiatives 
(the elton John aidS Foundation, Johnson 
& Johnson, M•a•c aidS Fund); the diana, 
Princess of Wales Memorial Fund’s Palliative 
care initiative; the Greater than aidS initiative, 
a project by the Kaiser Family Foundation 
and the black aidS institute supported by the 
Ford Foundation, M•a•c aidS Fund and the 
elton John aidS Foundation; funding domestic 
(aidS Foundation of chicago) and international 
(the bill & Melinda Gates Foundation) syringe 
exchange programs; the power of funders 
to convene (Flowers heritage Foundation);  
supporting community partners (levi Strauss 
Foundation) and youth prevention & awareness 
programs (the MtV Staying alive Foundation); 
and improving the quality of life for people 
living with hiV/aidS in africa (comic relief).
Fcaa and eFG are pleased that this inaugural 
effort to create a network of US and eU 
funders was so well received and believe 
that this reflects a genuine interest on the 
part of funders to network beyond borders. 
our organizations plan to build on the 
momentum of this initial event to strengthen 
the global field of hiV/aidS philanthropy.
BUILDING GLOBAL PARTNERS, VIENNA
together, Funders concerned 
about aidS (Fcaa) and the 
european hiV/aidS Funders 
Group (eFG) have been 
tracking the field of hiV/aidS 
philanthropy for close to a 
decade, with a collaborative 
goal of creating the most 
comprehensive portrait 
possible of global hiV/aidS-
related institutional philanthropy in an effort to 
facilitate greater coordination and transparency 
among funders and encourage expanded 
philanthropic support for hiV/aidS work. 
While our combined networks disbursed 
approximately $738 million dollars in hiV/aidS-
related philanthropy, Fcaa and eFG understand 
the critical need to explore and identify shared 
funding synergies and resulting gaps among 
funders from across the United States and 
europe. as an initial step in creating dialogue 
among our networks, Fcaa and eFG convened 
its first-ever joint reception in July 2010 at the 
XViii international aidS conference in Vienna 
to increase networking, find commonalities and 
explore ways of working together to address  
hiV/aidS more effectively.
More than 200 representatives from 75 private, 
public and multilateral funding organizations 
attended the “convening and connecting  
hiV/aidS Philanthropy: building Global Partners” 
reception for an evening of networking and 
inspirational keynote addresses from bill Gates, 
co-chair and trustee, the bill & Melinda Gates 
Foundation, and annie lennox, Founder, Sing.
after a full hour of cocktails and canapés, 
funders focused on networking with colleagues 
from across the U.S. and europe. Postcards 
disbursed throughout the reception acted as 
conversation starters by depicting images and 
stories of innovation in aidS funding, including: 
DEVELOPING CONNECTIONS BETWEEN U.S. AND EUROPEAN FUNDERS
Bill Gates
Annie Lennox
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Sixty-seven funders are categorized as “top” HIV/AIDS funders because they reported HIV/AIDS-
related grantmaking disbursements of $300,000 or more in 2009. All are listed in Table 1.
Table 1:
Top 67 U.S. HIV/AIDS Funders in 2009
(ranked by amount of disbursements)22
Name Disbursements ($) Commitments ($)
1. Bill & Melinda Gates Foundation, WA 333,707,265	 	 183,706,666
2. The Ford Foundation, Ny 27,684,607	 	 35,206,297
3. Abbott and Abbott Fund, IL 25,873,319	 	 25,873,319
4. Merck, NJ 21,507,000	 	 Not available
5. M•A•C AIDS Fund and M•A•C Cosmetics, Ny 19,536,172	 	 22,817,236
6. Philip T. and Susan M. Ragon Institute Foundation, MA 18,000,000	  Not available
7. Bristol-Myers Squibb Foundation 
 and Bristol-Myers Squibb Co., Ny23 12,621,390	 	 6,022,636
8. Johnson & Johnson, NJ 10,285,430	 	 10,285,430
9. Open Society Institute, Ny24 9,825,507	 	 9,825,507
10. Pfizer Inc and Pfizer Foundation, Ny25 8,952,422  Not available
11. broadway cares/equity Fights aidS, nY 7,907,800*  7,907,800
12. irene diamond Fund, nY 7,619,943  6,083,631
13. elton John aidS Foundation, nY 5,302,002*  550,000
14. national aidS Fund, dc 4,853,409*  5,168,566
15. the Foundation for aidS research (amfar), nY 4,418,488*  3,889,416
16. robin hood Foundation, nY 4,235,000  4,235,000
17. elizabeth Glaser Pediatric aidS Foundation, ca 3,821,121  3,636,026
22 the state associated with each entity refers to the state in which the entity is based, not necessarily where grants 
and projects are funded by the entity.
23 an additional $3 million in 2009 was reported from bristol-Myers Squibb Foundation and bristol-Myers Squibb 
company (bMS) for domestic advocacy initiatives shortly before the report was published, and thus could not be 
included in the overall findings due to the publication’s timeline. however, this additional funding amount brings total 
disbursements for bMS to $15,621,390 in 2009.
24 the 2009 dollar amounts provided by the open Society institute are estimates and not exact figures. these 
estimated disbursements only reflect external, hiV/aidS-related cash grants from 1) the Soros Foundation network’s 
Public health Program, 2) the burma Project, and 3) national and regional foundations. these numbers do not include 
hiV/aidS funding from any other programs within the Soros Foundations network, though it is possible that other 
programs within the Soros Foundations network may also have provided hiV/aidS-related funding in 2009.
25 this figure includes grants from both Pfizer inc and the Pfizer Foundation, but should be regarded as an estimate 
that does not include all hiV/aidS funding due to the unavailability of complete data.
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Table 1, continued 
 
Name Disbursements ($) Commitments ($)
18. international treatment Preparedness coalition (itPc), 
 a project of the tides center, ca26 3,362,993*  3,362,993
19. the Starr Foundation, nY 3,000,000  not available
20. United nations Foundation, dc 2,812,003*  2,812,003
21. levi Strauss & co., ca 2,498,000  2,498,000
22. american Jewish World Service, nY 2,362,581  3,708,787
23. Global Fund for Women, ca 2,341,320*  2,552,960
24. tides Foundation, ca27  2,306,887  2,306,887
25. GlaxoSmithKline US, nc28  2,041,405  not available
26. aidS Foundation of chicago, il 2,029,250*  2,029,250
27. W. M. Keck Foundation, ca 2,000,000  not available
28. the david and lucile Packard Foundation, ca 1,830,000  1,300,000
29. robert Wood Johnson Foundation, nJ 1,738,601  1,738,601
30. Wells Fargo, ca 1,726,952  not available
31. Pride Foundation, Wa 1,649,132  1,649,132
32. rockefeller brothers Fund, inc., nY 1,582,500  620,000
33. the new York community trust, nY 1,518,000*  1,518,000
34. Kate b. reynolds charitable trust, nc 1,492,611  236,500
35. John d. & catherine t. Macarthur Foundation, il 1,456,000  750,000
36. the William and Flora hewlett Foundation, ca 1,380,000  1,530,000
37. Washington aidS Partnership, dc 1,270,456*  1,130,640
38. design industries Foundation Fighting aidS (diFFa), nY 1,247,745*  1,247,745
39. conrad n. hilton Foundation, ca 1,245,000  not available
40. South africa development Fund, Ma 1,069,994*  1,079,994
41. James b. Pendleton charitable trust, Wa 1,055,979  1,055,979
42. Glaser Progress Foundation, Wa 1,000,000  1,000,000
43. San Francisco aidS Foundation, ca 953,549*  not available
26 itPc is fiscally managed by tides center, and all itPc grants are therefore legally made from tides Foundation. For 
the purposes of this report, however, itPc and the tides Foundation have reported separately.
27 the tides Foundation figure does not include grants made by the international treatment Preparedness coalition 
(itPc), a project of tides center that for the purposes of this report has been listed separately.
28 the figure for GlaxoSmithKline includes grants data from the U.S. branch of the company only. the company is 
headquartered in the United Kingdom, and non-U.S. hiV/aidS funding (approximately $4.7 million in 2009) is tracked in 
the european hiV/aidS Funders Group (eFG) resource tracking report (see www.hivaidsfunders.org to view the report, 
European Philanthropic Support to Address HIV/AIDS in 2009).
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Table 1, continued
 
Name Disbursements ($) Commitments ($)
44. comer Foundation, il 857,500  857,500
45. h. van ameringen Foundation, nY 835,000  not available
46. Max M. and Marjorie S. Fisher Foundation, inc., Mi 800,000  not available
47. alphawood Foundation, il 757,000  757,000
48. Until there’s a cure, ca 739,219  739,219
49. Staying alive Foundation, nY 732,552*  727,302
50. bd (becton, dickinson and company), nJ 611,686  not available
51. W. K. Kellogg Foundation, Mi 610,000  not available
52. aidS Funding collaborative, oh 602,788  507,211
53. Missouri Foundation for health, Mo 576,506  285,000
54. alliance healthcare Foundation/San diego  
 hiV Funding collaborative, ca 555,988  555,988
55. doris duke charitable Foundation, nY 505,000  not available
56. children affected by aidS Foundation, ca 453,003*  453,003
57. evelyn and Walter haas, Jr. Fund, ca 452,500  362,000
58. atlanta aidS Partnership Fund, Ga 450,000  not available
59. the Summit Foundation, dc 435,000  385,000
60. the health Foundation of Greater indianapolis, in 424,550  523,020
61. John M. lloyd Foundation, ca 405,000  255,000
62. Macy’s Foundation, oh 404,500  not available
63. Silicon Valley community Foundation, ca 357,600  not available
64. houston endowment inc., tX 337,500  325,000
65. boston Foundation, inc., Ma 321,215  150,000
66. the campbell Foundation, Fl 303,047  303,047
67. arcus Foundation, Mi 300,000  not available
 
2009 HIV/AIDS Grantmaking Disbursements by Top 6729    $570,993,240
2009 HIV/AIDS Grantmaking Commitments by Top 67    $366,350,291
Total 2009 U.S. HIV/AIDS Grantmaking Disbursements    $585,310,939
29 Funders with an asterisk (*) after their total reported that they received some financial resources from other agencies 
tracked by Fcaa. at least some of these funds were then re-granted to support hiV/aidS-related funding to other 
institutions. to avoid double counting of funds, the top 67 funders subtotal reflects a reduction of $14,955,747 to correct 
for re-granting of funds from one Fcaa-tracked top grantmaker to another. the total amount for all grantmakers also 
reflects a reduction of $14,965,747 to account for re-granting of funds from one Fcaa-tracked grantmaker to another. 
See the appendix for a more full explanation of the methodology used for this report.
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HIV/AIDS funding by U.S.-based private philanthropic funders is heavily concentrated among 
a relatively small number of entities. Funding disbursements from the largest U.S. HIV/AIDS 
grantmaker, the Bill & Melinda Gates Foundation, accounted for 57% of all identified  
HIV/AIDS grantmaking disbursements in 2009. The top 10 U.S. HIV/AIDS funders, including 
the Bill & Melinda Gates Foundation, accounted for 83% of all identified HIV/AIDS grantmaking 
disbursements in 2009 (approximately the same as in 2008). 
Chart 3: 
Distribution of Disbursements by Amount of U.S. HIV/AIDS Funders in 2009 
(by percentage of total disbursements)
largest funder 
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Among the top 67 U.S.-based HIV/AIDS funders for which FCAA had disbursements data for 2005 
through 2009 (49 of 67 funders), a total of 37 reported a higher level of HIV/AIDS grantmaking 
disbursements in 2009 than in 2005. Thirty-one funders (of 63 for which two years of data were 
available) reported higher amounts of disbursements in 2009 compared with 2008.
Table 2:
U.S. HIV/AIDS Funders Reporting Higher Amounts of HIV/AIDS Grantmaking Disbursements  
in 2009 than 2005
(ranked by size of monetary increase between reported amounts for those years)
      Change % 
Name 2005 ($) 2006 ($) 2007 ($) 2008 ($) 2009 ($) 05–09 ($) Change
bill & Melinda Gates  
Foundation, Wa 137,546,593 257,855,885 308,917,741 378,482,751 333,707,265 196,160,672 143%
Merck, nJ 8,340,000 15,696,000 15,937,739 13,368,736 21,507,000 13,167,000 158%
the Ford  
Foundation, nY 14,692,292 22,669,531 18,482,541 27,777,195 27,684,607 12,992,315 88%
M•a•c aidS  
Fund and M•a•c  
cosmetics, nY 9,122,623 16,187,422 22,042,057 23,461,948 19,536,172 10,413,549 114%
Johnson &  
Johnson, nJ 7,812,000 12,925,000 12,490,000 11,667,000 10,285,430 2,473,430 32%
national aidS  
Fund, dc 2,568,944 2,743,538 3,065,892 4,750,273 4,853,409 2,284,465 89%
american Jewish  
World Service, nY 309,008 1,839,061 1,538,960 1,640,623 2,362,581 2,053,573 665%
abbott and abbott  
Fund, il 23,933,226 19,474,610 26,449,721 25,229,419 25,873,319 1,940,093 8%
the Foundation for  
aidS research  
(amfar), nY 2,568,944 2,812,983 2,085,840 5,100,050 4,418,488 1,849,544 72%
the david and  
lucile Packard  
Foundation, ca 250,000 750,000 1,270,000 550,000 1,830,000 1,580,000 632%
Pride Foundation,  
Wa 73,000 73,000 77,864 1,316,952 1,649,132 1,576,132 2159%
elton John aidS  
Foundation, nY 3,884,391 4,805,874 6,288,676 6,375,034 5,302,002 1,417,611 36%
robin hood  
Foundation, nY 2,845,000 3,805,000 4,275,000 4,895,000 4,235,000 1,390,000 49%
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Table 2, continued 
      Change % 
Name 2005 ($) 2006 ($) 2007 ($) 2008 ($) 2009 ($) 05–09 ($) Change 
robert Wood  
Johnson  
Foundation, nJ 349,986 299,930 273,944 489,970 1,738,601 1,388,615 397%
United nations  
Foundation, dc 1,531,278 6,708,922 1,537,977 753,346 2,812,003 1,280,725 84%
Global Fund for  
Women, ca 1,132,924 1,371,583 1,961,758 1,968,090 2,341,320 1,208,396 107%
irene diamond  
Fund, nY 6,426,715 6,690,905 7,127,787 8,305,366 7,619,943 1,193,228 19%
Kate b. reynolds  
charitable trust, nc 334,339 459,052 1,016,499 256,534 1,492,611 1,158,272 346%
conrad n. hilton  
Foundation, ca 199,300 1,531,200 86,000 66,000 1,245,000 1,045,700 525%
the new York  
community trust, nY 730,000 1,330,000 1,545,450 1,746,000 1,518,000 788,000 108%
the design industries  
Foundation Fighting  
aidS (diFFa), nY 594,807 683,000 1,221,290 1,026,131 1,247,745 652,938 110%
aidS Foundation  
of chicago, il 1,435,148 1,785,401 1,186,594 1,663,982 2,029,250 594,102 41%
aidS Funding  
collaborative, oh 49,565 424,232 386,398 544,763 602,788 553,223 1116%
South africa  
development  
Fund, Ma 614,041 638,455 686,828 686,928 1,069,994 455,953 74%
Glaser Progress  
Foundation, Wa 550,000 1,500,000 1,525,000 273,481 1,000,000 450,000 82%
Washington aidS  
Partnership, dc 821,675 1,010,800 1,193,050 1,354,984 1,270,456 448,781 55%
levi Strauss &  
co., ca 2,124,958 2,212,370 1,876,100 1,809,000 2,498,000 373,042 18%
bd (becton, dickinson  
and company), nJ 243,200 837,464 650,000 524,000 611,686 368,486 152%
Until there’s a  
cure, ca 383,300 942,308 758,500 210,322 739,219 355,919 93%
the John d. &  
catherine t. Macarthur  
Foundation, il 1,138,000 1,336,000 1,817,000 615,000 1,456,000 318,000 28%
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Table 2, continued 
      Change % 
Name 2005 ($) 2006 ($) 2007 ($) 2008 ($) 2009 ($) 05–09 ($) Change 
the William and  
Flora hewlett  
Foundation, ca 1,075,000 1,390,417 2,100,000 900,000 1,380,000 305,000 28%
Wells Fargo, ca 1,470,175 1,490,089 1,607,101 1,722,269 1,726,952 256,777 17%
boston Foundation,  
inc., Ma 80,000 110,000 140,280 713,850 321,215 241,215 302%
the health  
Foundation of Greater  
indianapolis, in 250,000 350,000 403,875 394,740 424,550 174,550 70%
arcus Foundation,  
Mi 142,000 847,890 220,000 510,000 300,000 158,000 111%
the comer  
Foundation,il 724,836 806,000 1,140,000 940,775 857,500 132,664 18%
the John M. lloyd  
Foundation, ca 404,175 410,000 390,000 484,550 405,000 825 0%
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Of the top 67 funders for which FCAA had HIV/AIDS grantmaking disbursement data from 
2005 through 2009 (49 of 67 funders), a total of 12 reported disbursing less in 2009 than in 2005. 
Thirty-two funders (of 63 for which two years of data were available) reported disbursing less in 
2009 than in 2008. It should be noted that some changes in funding are not indicative of larger 
trends of decreases in funding for some funders. Many funders make multi-year commitments, and 
expenditures of those commitments can vary greatly between years.
Table 3:
U.S. HIV/AIDS Funders Reporting Lower Amounts of HIV/AIDS Grantmaking Disbursements in  
2009 than 2005
(ranked by size of monetary decrease between reported amounts for those years)
      Change % 
Name 2005 ($) 2006 ($) 2007 ($) 2008 ($) 2009 ($) 05–09 ($) Change 
bristol-Myers Squibb  
Foundation and  
bristol-Myers Squibb  
company, nY 26,806,679 31,935,113 15,996,612 10,383,997 12,621,390 -14,185,289 -53%
elizabeth Glaser  
Pediatric aidS  
Foundation, ca30 8,580,706 8,619,232 5,821,951 4,168,868 3,821,121 -4,759,585 -55%
Missouri Foundation  
for health, Mo 1,667,440 2,147,438 1,086,099 1,185,662 576,506 -1,090,934 -65%
alphawood  
Foundation, il 1,700,600 2,255,000 570,000 1,057,000 757,000 -943,600 -55%
W. K. Kellogg  
Foundation, Mi 1,045,000 1,520,073 1,450,000 1,985,000 610,000 -435,000 -42%
the campbell  
Foundation, Fl 603,400 652,668 644,687 442,946 303,047 -300,353 -50%
children affected by  
aidS Foundation, ca 749,686 911,364 909,986 1,057,593 453,003 -296,683 -40%
houston endowment  
inc., tX 550,000 1,040,000 435,000 522,500 337,500 -212,500 -39%
h. van ameringen  
Foundation, nY 933,500 1,178,000 1,434,000 1,091,000 835,000 -98,500 -11%
evelyn and Walter  
haas, Jr. Fund, ca 532,000 585,000 280,000 645,000 452,500 -79,500 -15%
broadway cares/equity  
Fights aidS, nY 7,986,298 8,035,864 8,824,046 10,039,298 7,907,800 -78,498 -1%
rockefeller brothers  
Fund, inc., nY 1,650,000 1,624,500 2,050,000 2,550,000 1,582,500 -67,500 -4%
30 While elizabeth Glaser Pediatric aidS Foundation’s re-granting to other organizations utilizing private funds 
continued to decrease in 2009, this does not reflect a decrease in the overall Foundation re-granting budget, which 
increased significantly during 2005—09, primarily with public funding. the Foundation’s publicly funded re-granting 
budget went from roughly $30 million in 2005 to about $56 million in 2009. however, private funding as a proportion of 
overall re-granting declined from 23% in 2005 to only 7% in 2009.
27U.S. PhilanthroPic SUPPort to addreSS hiV/aidS in 2009
2010 forecAst
In the FCAA survey on 2009 funding, funders were asked about their anticipated grantmaking 
levels for 2010. Of the HIV/AIDS funders that responded to this survey question (52 of 67), 29% 
indicated that they expected an increase in HIV/AIDS grantmaking in 2010 in comparison with 
2009, including four of the top 10 funders. Thirty-three percent of funders, however, forecast their 
2010 grantmaking levels would be less than in 2009, including the top funder, the Bill & Melinda 
Gates Foundation.31 Thirty-eight percent (20 of 52 responding) reported that they anticipate 
disbursements to remain at approximately the same level or were unsure.
Chart 4: 
Forecast of 2010 U.S. Philanthropic HIV/AIDS Funding
(by percentage of funders responding)
31 a large portion of the expected decrease in hiV/aidS disbursements from the bill & Melinda Gates Foundation in 
2010 will be a result of their procedure of disbursing both 2009 and 2010 commitments to the Global Fund in 2009.  
See page 36 for more detail about the Gates Foundation’s contribution to the Global Fund in 2009.
expect funding to decrease in 2010 33%
expect funding to remain the same in 2010,  
or unsure of likely levels 38%
expect funding to increase in 2010 29%
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UNDERSTANDING CONTEXT
THE FCAA SPOTLIGHT: STATE BUDGET CUTS, A FUNDER BRIEFING IN OAkLAND
HIV/AIDS grantmakers and key stakeholders 
came together on October 7, 2010 at the 
California Endowment in Oakland, CA to discuss 
the impact of state budget cuts on HIV/AIDS 
programs across the country. 
Julie Scofield, executive director of the national 
alliance of State & territorial aidS directors 
(naStad), opened with an overview of the 
state funding environment. in 2009, 29 states 
reported a loss of $170 million in their hiV/aidS 
and viral hepatitis programs, and in 2010, 28 
states reported an additional loss of $52 million. 
Forty-one states have reported over 200 open or 
unfilled hiV/aidS or viral hepatitis-related public 
health positions over the past two years, with 
other states instituting mandatory furloughs and 
pay and/or hiring freezes. States are also cutting 
prevention and treatment programs, including: 
prevention training, provision of testing services, 
behavioral interventions, condoms, and syringe 
exchange programs.
While the gap between need and available 
resources is immense—the cuts in 2009 budgets 
alone is 34% greater than total domestic 
disbursements by philanthropic hiV/aidS 
funders in the same year—Scofield highlighted 
a few opportunities in the road ahead. Seven 
states in 2010 reported the restoration of $55.3 
million in state funding, mostly for the aidS 
drug assistance Programs (adaPs). She urged 
funders to support the local and state advocacy 
necessary to ensure both the national hiV/aidS 
Strategy and healthcare reform will be fully 
funded and implemented.
“innovations in Funding,” moderated by 
Kandy Ferree, President & ceo of the national 
aidS Fund, brought together the california 
endowment, bristol-Myers Squibb and the bay 
area Positive network for health to discuss 
why and how they are shifting their funding 
paradigms within the new funding environment. 
the panel found a strong theme in the role of 
supporting both advocacy and community 
infrastructure over the long term to ensure 
systems change. the discussion also underscored 
the essential need to approach the work more 
holistically—across funding issues and portfolios—
to strengthen a broader network of advocacy and 
create sustained impact. 
convened in oakland, the briefing provided the 
opportunity to view the public funding context 
in a city poised to tell two stories: one of crisis, 
and one of response. Since 1998 alameda county 
(including oakland, which accounts for 65% 
of the county’s total hiV/aidS cases) has been 
fighting a state of emergency directly related 
to hiV/aidS cases within the african american 
community. in 2007 keynote speaker oakland 
Mayor ronald V. dellums became one of the first 
U.S. Mayors to be publicly tested for hiV/aidS. 
by becoming the public face of hiV/aidS testing 
in oakland – and launching the city’s innovative 
Get Screened Oakland (GSo)—the Mayor hopes 
to help take the stigma out of hiV testing, and to 
promote that everyone know their status. Mayor 
dellums urged funders to help scale up this 
testing model nationally. 
dr. Marsha Martin, director of GSo, was joined 
by partners from the levi Strauss Foundation, 
Flowers heritage Foundation, the Global 
business coalition on hiV/aidS, tuberculosis 
Jessica Riviere, Bristol-Myers Squibb; Cynthia 
Gomez, Health Equity Institute, San Francisco State 
University; Kandy Ferree, National AIDS Fund; and 
John Barnes, FCAA 
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and Malaria (Gbc), and chevron to discuss the 
challenges and successes behind its public-
private partnership model. the original question 
behind GSo was, in a city such as oakland—with 
finite borders—how do you target hiV/aidS 
assistance and messages, and importantly, how 
do you understand where the virus is? the goal 
behind GSo was to make hiV/aidS everybody’s 
business in oakland, and to do this, it needed 
multi-sector partners to help fully reach into the 
community. GSo invited all partners—including 
corporate and family foundations, both aidS and 
non-aidS community service providers, and the 
corporate sector—to the table from its inception 
to collaboratively determine what support and 
unique skills they could offer. the partners’ 
leadership has also played an important role in 
encouraging others from beyond the hiV/aidS 
community to work on hiV.   
the final panel encapsulated the day’s themes 
with a discussion among young leaders from 
World, the downtown Youth clinic (east 
bay aidS center), Pacific center for human 
development and la clinica de la raza who 
shared examples of innovative programming in 
oakland: an on-site bathhouse drop-in therapist, 
positive women-led peer networks, community 
outreach programs focused on at-risk latino 
populations, and a youth-focused social network 
hiV testing initiative. it became clear that while 
there has been a lot of effort in scale up of both 
hiV testing and awareness in the oakland area, 
their care and support services are extremely 
strained. Panelist naina Khanna, director of Policy 
and community organizing at World, reminded 
funders that while we look to the aidS Service 
organization community to help achieve the care, 
prevention and health disparities goals of the new 
national hiV/aidS Strategy, we cannot afford to 
scale back investment in these organizations that 
provide culturally competent services grounded 
in community. Panelists agreed that they need 
funders’ help to innovate, evaluate, collaborate 
and leverage other funding. the panelists also 
asked for flexibility in funding, and the time 
for a formative phase to support research, 
needs assessment and information gathering. 
Moderator Gregory edwards, executive director 
of the Flowers heritage Foundation, ended the 
session by congratulating their leadership and 
underscoring the need for funders to invest in 
new leaders in a sustainable way. 
Get Screened Oakland Panel. Miguel Bustos,  
Levi Strauss Foundation; Dr. Marsha Martin, Get 
Screened Oakland; Gregory Edwards, Flowers 
Heritage Foundation; John Newsome, GBC; and 
Ernesto De La Torre, Chevron
Community Innovations Panel. Naina Khanna, 
WORLD; Alex Williams, Downtown youth Center, 
East Bay AIDS Center; Angel Fabian, La Clinica de  
la Raza; and Aaron Testard, Pacific Center for 
Human Development.
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U.s. corPorAte hiV/Aids fUnders
In 2009, 11 corporate foundations and giving programs were among the top 67 U.S.-based  
HIV/AIDS funders identified by FCAA. The total estimated support of these 11 entities in 2009 
was $106 million (1,475 grants), representing 18% of the $585 million total estimated HIV/AIDS 
U.S. philanthropy for 2009, and a 7% increase in the amount of corporate giving compared with 
results reported for the 11 top corporate funders for 2008.32 
Table 4: 
Top U.S. Corporate HIV/AIDS Funders in 2009 
(ranked by amount of disbursements)
abbott and abbott Fund, il   $25,873,319
Merck, nJ   21,507,000
M•a•c aidS Fund and M•a•c cosmetics, nY   19,536,172
bristol-Myers Squibb Foundation and bristol-Myers Squibb company, nY   12,621,390
Johnson & Johnson, nJ   10,285,430
Pfizer inc and Pfizer Foundation, nY   8,952,422
levi Strauss & co., ca   2,498,000
GlaxoSmithKline US, nc   2,041,405
Wells Fargo, ca   1,726,952
bd (becton, dickinson and company), nJ   611,686
Macy’s Foundation, oh   404,500
 
Total   $106,058,276
2010 Corporate Forecast
Eight of the 11 corporate funders listed in Table 2 provided FCAA with information about their 
grantmaking, including whether they expected their HIV/AIDS-related funding to increase 
or decrease in 2010. Three of the corporate funders forecasted funding to be higher in 2010 in 
comparison with 2009. Three expected grantmaking to remain about the same, and two funders 
said they expected funding to be lower in 2010.
32 Fcaa reported $99.6 million in disbursements among the top 11 corporate hiV/aidS funders in 2008.
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Among the top 67 U.S.-based HIV/AIDS funders in 2009, a total of 53 (80%) provided data on  
the geographic distribution of their funding disbursements. FCAA gathered geographic 
distribution data for 12 other funders from the Foundation Center, Foundation Search, grants 
databases on a funder’s website, or 990 tax forms, but could not obtain data on geographic 
distribution for two of the top 67 HIV/AIDS funders.  
Analysis by FCAA suggests that of the estimated $585 million disbursed in 2009 by the top  
67 funders, at least $472 million (81%) was directed to global or international HIV/AIDS work 
(including funds granted to U.S. organizations for international work). At least $112 million was 
disbursed to domestic U.S. HIV/AIDS efforts, representing 19% of the amount of all HIV/AIDS 
grants disbursed by the top 67 funders. The geographic distribution of the remaining funds 
(approximately $1.7 million, or less than 1%) could not be identified. In 2008, the figure for 
international funding was $521 million (an amount 9% higher than 2009), and the figure for 
domestic funding was $98 million (14% lower than the 2009 total).
Chart 5: 
Grant Dollar Disbursements in 2009 by Geographic Focus 
(by percentage of total expenditure)
geogrAPhic distribUtion of hiV/Aids grAnts
For international projects (funders other than  
the bill & melinda Gates Foundation) 24%
Unspecified <1%
bill & melinda Gates Foundation  
(for international projects) 57%
For domestic U.S. epidemic (funders other than  
the bill & melinda Gates Foundation) 19%
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GeoGraPhic diStribUtion oF hiv/aidS GrantS
Data collected by FCAA indicate that, in 2009, 23% of funders provided funding exclusively to 
address the epidemic internationally (15 of 65 funders), while 39% of funders provided funding 
exclusively to address the epidemic domestically (26 of 65 funders). These findings indicate a 
decrease in the share of funders focused exclusively on the international epidemic: in 2008, nearly 
one-third (32%) of those funders for which FCAA was able to gather geographic distribution data 
were focused exclusively on the epidemic outside of the United States.
Chart 6: 
Geographic Focus of U.S. HIV/AIDS Funders in 2009
(by percentage of funders responding to question)
U.S. and international focus 38%
U.S. domestic focus only 39%
international focus only 23%
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THE LEVI STRAUSS FOUNDATION
in June 2010 healthright international presented 
their annual corporate leadership award to levi 
Strauss & co. in recognition of their longstanding 
commitment to health and human rights. 
daniel lee, executive director of the levi Strauss 
Foundation (lSF), shared the history of the levi 
Strauss response to the global epidemic dating 
back to 1982 when robert d. haas—ceo at 
the time—and other leaders helped to pass out 
leaflets at their San Francisco headquarters to 
educate their employees about hiV (then known 
as Grid, or Gay-related immune disorder). in 
1983 lSF became the first corporate foundation 
to make a hiV/aidS-specific donation to the 
funding of the Kaposi Sarcoma clinic at the San 
Francisco General hospital. in the more than two 
decades since, the company and Foundation 
have provided more than $45 million in social 
investments that have helped build several  
hiV/aidS service and advocacy organizations 
from the ground up in San Francisco and in over 
30 countries around the world. 
lee also highlighted the four core values 
embraced by levi Strauss and co. and the 
Foundation that serve as the guiding light not 
only for its business practices, but also their 
response to hiV/aidS: originality, empathy, 
integrity and courage. “In our programs, 
policies and campaigns, we have sought to be 
pioneering, bold and honest,” said Lee. “We have 
sometimes raised a few eyebrows along the way, 
but as Jonathan Mann (founder of HealthRight 
International) would point out: if you’re not 
rabble-rousing and raising eyebrows, you’re 
probably not on the right track.”
A Focus on Human Rights
hiV/aidS is arguably the most stigmatized 
medical condition in human history. it is also well 
documented that hiV/aidS stigma and 
discrimination are often intertwined with 
discrimination attached to being a woman, being 
poor, having a different sexual orientation, 
engaging in sex work or drug use, or being in 
prison. lSF firmly believes that to ensure the 
effectiveness of hiV/aidS responses, it is paramount 
to protect the human rights of highly marginalized 
groups—including sex workers, gay and bisexual 
men, prisoners and people who use drugs.
lSF’s hiV/aidS grantmaking strategy focuses 
on driving social change to address this unique 
nature of hiV/aidS. Selected milestones include:
1. implementation of a gender-based violence 
and stigma reduction initiative covering all 
apparel workers in lesotho, a country where two 
of every five adults is living with hiV.
2. the Foundation co-sponsored the second 
“human rights networking Zone” at the 
international aidS conference in Vienna in July 
2010. Serving as a common space for advocates 
to gather, learn and mobilize, the Zone’s activities 
engaged participants in campaigns to end 
hiV-related human rights abuses and included 
sessions highlighting the innovation of grantees. 
lSF also supported mini-conferences on 
international legal advocacy to bolster hiV/aidS 
prevention among sex workers and to promote 
treatment access. 
3. lSF supports four leading organizations—aidS 
law Project (South africa), canadian hiV/aidS 
legal network, lawyers collective (india) and 
human rights Watch (U.S.)—that are regarded 
as the global ‘bellwethers’ in the arenas of legal 
advocacy and policy change.
4. the Foundation also supports the United 
nations Special rapporteur on the right to 
health, a new position serving as a global voice 
on rights violations related to health. anand 
Grover, who currently holds this position, is a 
leading hiV/aidS lawyer from Mumbai, india. 
5. lSF also embraces community mobilization 
and the development of new leaders in the  
hiV/aidS field to take advantage of opportunities 
to engender social change.
EXAMPLES OF INNOVATIVE FUNDING
A HUMAN RIGHTS APPROACH 
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focUs on internAtionAl hiV/Aids fUnding
FCAA identified 25 funders out of the top 67 funders that disbursed $1,000,000 or more to support 
international AIDS programming in 2009.  
Table 5:
U.S. HIV/AIDS Funders Disbursing $1,000,000 or More to HIV/AIDS Projects  
Outside of the U.S. in 2009
(ranked by amount of international disbursements)
  % of total 
  HIV/AIDS 
  disbursements 
 International ($) by funder
bill & Melinda Gates Foundation, Wa 333,707,265  100
abbott and abbott Fund, il 24,921,814  96
Ford Foundation, nY 22,642,441  82
Merck, nJ 12,376,000  58
open Society institute, nY 9,825,507  100
M•a•c aidS Fund and M•a•c cosmetics, nY 9,439,592  48
Johnson & Johnson, nJ 8,984,430  87
bristol-Myers Squibb Foundation and  
bristol-Myers Squibb company, nY 7,634,631  60
Pfizer inc and Pfizer Foundation, nY 5,297,867  59
elizabeth Glaser Pediatric aidS Foundation, ca 3,821,120  100
international treatment Preparedness coalition (itPc),  
a project of the tides center, ca 3,362,993  100
the Starr Foundation, nY 3,000,000  100
United nations Foundation, dc 2,812,003  100
american Jewish World Service, nY 2,362,581  100
Global Fund for Women, ca 2,341,320  100
elton John aidS Foundation, nY 2,025,000  38
the Foundation for aidS research (amfar), nY 1,942,045  44
the david and lucile Packard Foundation, ca 1,830,000  100
levi Strauss & co., ca 1,583,000  63
rockefeller brothers Fund, inc., nY 1,582,500  100
John d. & catherine t. Macarthur Foundation, il 1,456,000  100
the William and Flora hewlett Foundation, ca 1,380,000  100
conrad n. hilton Foundation, ca 1,239,000  100
South africa development Fund, Ma 1,079,994  100
Glaser Progress Foundation, Wa 1,000,000  100
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FocUS on international hiv/aidS FUndinG
Of the top 67 funders in 2009, FCAA identified 39 that disbursed funds to address the  
international epidemic.
Chart 7: 
Regional Geographic Distribution of International HIV/AIDS Philanthropic Funding  
in 2009 by U.S. Funders
(by percentage of total international disbursements)
Global Fund 20%
Who, Un, etc. 4%
Unspecified <1%




Western & central europe 2%
eastern europe & central asia 3%
Western & central africa 8%
eastern & Southern africa 33%
north africa & middle east <1% 
South asia & Pacific 11%
east asia & Southeast asia 7% 
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There was an increase in the total share from 1% to 2% in 2008 and 2009, respectively, for Western 
and Central Europe—which corresponded to a total of $4 million in 2008 and $7.5 million in 
2009—and from 3% to 4% of the respective total in 2008 and 2009 for WHO, the UN, and other 
multilateral organizations ($14 million in 2008 and $20 million in 2009). There was also a slight 
increase of funding to U.S. organizations for international work33, from $45 million in 2008 to $46 
million in 2009.
The share of international funding allocated to several other regions was lower in 2009 than in 
2008. It declined from 36% in 2008 ($190 million) to 33% in 2009 ($158 million) in Eastern and 
Southern Africa; from 16% in 2008 ($82 million) to 11% in 2009 ($50 million) in South Asia and the 
Pacific; from 4% in 2008 ($19 million) to 3% in 2009 ($12 million) in Eastern Europe and Central 
Asia; from 3% in 2008 ($16 million) to 2% ($12 million) in Latin America; and from 1% in 2008 ($4 
million) to only slightly above 0% in 2009 ($2 million) in the Caribbean.34 
The Global Fund to Fight AIDS, Tuberculosis and Malaria received $93 million from 
U.S.-based philanthropies in 2009, of which 96% was disbursed directly from the Bill & 
Melinda Gates Foundation. Since 2001, the Bill & Melinda Gates Foundation has given 
$650 million to the Global Fund. For the last five years, the Foundation has provided $100 
million annually. In 2009, it is estimated that 45% of Global Fund disbursements went to 
HIV/AIDS35, and, therefore, 45% of the Foundation’s disbursement was allocated to HIV 
spending. Because the Bill & Melinda Gates Foundation provided two payments to the 
Global Fund in 2009 (for both 2009 and 2010), two payments of $45 million each have 
been attributed to HIV/AIDS for purposes of this report. This forward funding will lead to an 
expected decline in funding for HIV/AIDS from the Bill & Melinda Gates Foundation in 2010 
because a Global Fund payment will not be included in the total disbursements figure for 
the Bill & Melinda Gates Foundation for 2010. 
 
33 Funding for grantees with main offices in the United States that are known to use the grant money for work outside 
the U.S. are counted in the total international figure.
34 See appendix, page 49 for the full list of countries in each region, based on the UnaidS definitions of global regions.
35 www.theglobalfund.org/en/fundingdecisions/?lang=en#9
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FocUS on international hiv/aidS FUndinG
intended Use of internAtionAl hiV/Aids fUnding
FCAA was able to obtain data on intended use of international HIV/AIDS grants for 39 of the top 
67 U.S. HIV/AIDS funders in 2009. The charts below show both the 2008 and 2009 intended use of 
international funding totals for a year-to-year comparison. Chart 8a shows international intended 
use disbursements for all funders (including the Bill & Melinda Gates Foundation), while Chart 8b 
shows international intended use for funders other than the Bill & Melinda Gates Foundation.
For the 2010 survey on 2009 funding, FCAA added an additional intended use category  
of “Program management and administration” to be in better harmony with the UNAIDS  
intended use categories.
Chart 8a: 
International Intended Use of U.S. HIV/AIDS Philanthropic Funding in 2008 and 2009  
(All funders)
the “other” category for international intended use includes funding that was unspecified and funding for projects that did not fall 
under the pre-determined categories, such as: funding that fell across multiple categories and could not be broken down, long-term 
health systems strengthening, building and renovating labs and health care facilities, providing technical assistance to governments 
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Chart 8b: 
International Intended Use of U.S. HIV/AIDS Philanthropic Funding in 2008 and 2009  
(Funders other than the Bill & Melinda Gates Foundation)
the “other” category for international intended use includes funding that was unspecified and funding for projects that did not fall 
under the pre-determined categories, such as: funding that fell across multiple categories and could not be broken down, long-term 
health systems strengthening, building and renovating labs and health care facilities, providing technical assistance to governments 
and other organizations, conducting regional evaluations, organizational capacity-building, and support for gender and reproductive 
health programs.
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FocUS on international hiv/aidS FUndinG
Top U.S. HIV/AIDS funders were asked to identify the three population groups that receive the 
greatest benefit from their funding. (Some funders reported more than three populations as their 
main focus, but they were asked to list only the top three target populations of their funding.) 
Chart 9 shows the percentage of the 39 total respondents that chose each category. The categories 
are not mutually exclusive.
Chart 9: 
International Target Populations for U.S. HIV/AIDS Grantmaking in 2009
(by percentage of 39 top international funders from which target populations data were obtained)
the “other” category for international target populations included responses such as funding for all populations and funding for  
rural populations.
HCWs: health care workers 
IDUs: injecting drug users 
MSM: Men who have sex with men 
OVC: orphans and vulnerable children 
PLWHA: People living with hiV/aidS
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TIDES AFRICA FUND
co-developed with the hewlett Foundation in 
august 2007, the africa Family Planning and 
hiV integration Fund, or the tides africa Fund, 
seeks to leverage hiV/aidS funding to support 
the family planning and reproductive health 
fields in sub-Saharan africa that are serving the 
same populations as the hiV/aidS providers. 
the goal of the Fund is to support well-designed 
existing programs with the ability to measure and 
share program outcomes of integrated program 
models, and thus, contribute to the scientific 
legitimacy of the integration approach. 
in alignment with tides africa Fund’s evidence-
based model, selected organizations were 
required to have existing hiV/aidS programs 
and at least solid integration plans, as well as 
the ability to provide quantitative data on the 
benefits and constraints of their integration 
model. in addition, preference was given to those 
organizations with on-site counseling facilities or 
peer-led outreach programs.
during the first phase of the project (august 
2008), the fund awarded grants totaling more 
than $1.3 million to organizations in six different 
countries, including:  center for infectious 
disease research (cidrZ), Zambia; Family aidS 
care and education Services (FaceS), Kenya; 
Family health international (Fhi), tanzania; 
infectious disease institute (idi), Uganda; 
intrahealth international, rwanda; and Pathfinder 
international, Mozambique. 
originally the tides africa Fund’s strategy 
was designed to target and influence the 
US President’s emergency Plan for aidS 
relief (PePFar) to include stronger linkages 
between hiV/aidS and reproductive health 
services.  however, recent changes announced 
by the obama administration’s Global health 
initiative (Ghi) to prioritize the integration of 
the previously separate silos of hiV/aidS, family 
planning and maternal and child health called for 
a new approach. the fund’s focus shifted towards 
providing more information on policy change 
to its grantee partners; holding discussions on 
broader integration to leverage and support their 
current work focused on the Ghi and Millennium 
development Goals (MdGs); and finally, to 
increase the visibility and capacity of their 
grantee partners to take full advantage of the 
Ghi’s new focus on country-led programs. 
to achieve its goals, tides africa Fund brought 
grantee-partners together as a cohort to develop 
goals and outcomes for the fund, as well as to 
share essential information and best practices 
between organizations. currently at the six-
month mark of phase ii, the fund is focused 
on supporting the capacity and development 
of its grantee partners. based on the cohort’s 
recommendations, this includes increased 
resource development and supporting grantee 
information-sharing on policy changes and best 
practices. the fund also supports the cohort to 
meet on a quarterly basis by phone or in-person, 
as well as to create a quarterly newsletter to keep 
grantee partners engaged in the current state 
of integration. this collaborative approach has 
yielded additional benefits, with grantee partners 
recognizing their individual strengths and offering 
support to other countries. For example, idi in 
Uganda provides assistance with fundraising; 
intrahealth international in rwanda helps the 
grantees navigate working with ministries of 
health; and Fhi in tanzania shares their skills in 
curriculum development and networking. 
the next phase of the fund will include expanding 
to grantees from ethiopia, South africa and 
botswana. additionally, the fund will work on 
analyzing and translating its emerging qualitative 
and quantitative data and then sharing this 
information with other funders and leaders to 
promote investments for in-country leadership 
and integration models. 
EXAMPLES OF INNOVATIVE FUNDING
AN INTEGRATED APPROACH
41U.S. PhilanthroPic SUPPort to addreSS hiV/aidS in 2009
focUs on domestic U.s. hiV/Aids fUnding
FCAA identified 25 funders out of the top 67 funders that disbursed $1,000,000 or more to support 
domestic U.S. HIV/AIDS programming in 2009. 
Table 6: 
U.S. HIV/AIDS Funders Disbursing $1,000,000 or More to HIV/AIDS Projects  
Within the U.S. in 2009
(ranked by amount of domestic disbursements)
  % of total 
  HIV/AIDS 
  disbursements 
 Domestic ($) by funder
Philip t. and Susan M. ragon institute Foundation, Ma 18,000,000  100
M•a•c aidS Fund and M•a•c cosmetics, nY 10,096,580  52
Merck, nJ 9,131,000  42
irene diamond Fund, nY 7,619,943  100
broadway cares/equity Fights aidS, nY 7,592,800  96
Ford Foundation, nY 5,042,166  18
bristol-Myers Squibb Foundation and  
bristol-Myers Squibb company, nY 4,986,789  40
national aidS Fund, dc 4,853,409  100
robin hood Foundation, nY 4,235,000  100
Pfizer inc and Pfizer Foundation, nY 3,654,555  41
elton John aidS Foundation, nY 3,277,002  62
the Foundation for aidS research (amfar), nY 2,445,961  55
GlaxoSmithKline US, nc 2,041,405  100
W. M. Keck Foundation, ca 2,000,000  100
aidS Foundation of chicago, il 1,974,250  97
robert Wood Johnson Foundation, nJ 1,738,601  100
Wells Fargo, ca 1,724,302  100
Pride Foundation, Wa 1,649,132  100
the new York community trust, nY 1,518,000  100
Kate b. reynolds charitable trust, nc 1,492,611  100
tides Foundation, ca 1,418,750  62
Johnson & Johnson, nJ 1,301,000  13
Washington aidS Partnership, dc 1,270,456  100
design industries Foundation Fighting aidS (diFFa), nY 1,247,745  100
James b. Pendleton charitable trust, Wa 1,055,979  100
42 FUnderS concerned aboUt aidS
FocUS on domeStic U.S. hiv/aidS FUndinG
Chart 10 shows the U.S. regional distribution of domestic HIV/AIDS philanthropic funding. Of the 
top 67 funders in 2009, FCAA identified a total of 50 that disbursed funds to addressing the U.S. 
domestic epidemic. 
FCAA asks funders to report domestic funding according to where the office of the grantee is 
located. It is important to note that some funders’ grantees conduct HIV/AIDS work outside of 
the region in which they are based. Therefore, the share of funding given to a domestic region in 
Chart 10 is only an estimate of the actual funding spent in the region. Approximately 7% of total 
grantmaking to address U.S. domestic activities tracked by FCAA was not able to be identified  
by region.
Chart 10: 
Regional Distribution of Domestic U.S. HIV/AIDS Philanthropic Funding in 2009
(by percentage of total domestic disbursements)
In comparison with 2008, funding to the Northeast region increased in 2009, from $40 million to 
$53 million. Funding to the South also increased slightly, from $22 million in 2008 to $23 million in 
2009, as well as funding for the U.S. Territories (from $0.2 million in 2008 to $0.4 million in 2009). 
Funding to the West decreased from $20 million in 2008 to $19 million in 2009, and funding to the 
Midwest decreased from $12 million in 2008 to $10 million in 2009. Approximately $7 million was 
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Table 7: 
Top Domestic Funders by U.S. Region in 2009
(ranked by amount of disbursements to grantees based in each region)
Northeast 
Philip t. and Susan M. ragon institute Foundation, Ma $18,000,000
irene diamond Fund, nY 6,718,631
broadway cares/equity Fights aidS, nY 5,298,916
M•a•c aidS Fund and M•a•c cosmetics, nY 4,304,886
robin hood Foundation, nY 4,235,000
South 
national aidS Fund, dc $2,997,547
Ford Foundation, nY 2,816,500
M•a•c aidS Fund and M•a•c cosmetics, nY 2,570,574
Merck, nJ 2,362,000
Kate b. reynolds charitable trust, nc 1,492,611
Midwest 
aidS Foundation of chicago, il $1,974,250
Merck, nJ 1,186,000
M•a•c aidS Fund and M•a•c cosmetics, nY 877,026
aidS Funding collaborative, oh 602,788
national aidS Fund, dc 592,000
West 
Merck, nJ $4,895,000
M•a•c aidS Fund and M•a•c cosmetics, nY 2,269,094
Wells Fargo, ca 1,352,162
W. M. Keck Foundation, ca 1,000,000
broadway cares/equity Fights aidS, nY 806,883
FocUS on domeStic U.S. hiv/aidS FUndinG
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ELTON JOHN AIDS FOUNDATION
in July 2010 the obama administration  
released the seminal national hiV/aidS 
Strategy—a national plan focused on addressing 
the U.S. epidemic by reducing hiV incidence, 
increasing access to care, and reducing  
hiV-related health disparities. the national  
hiV/aid Strategy represents a seismic shift in  
the way the United States approaches the 
domestic response to hiV/aidS, namely, with  
a renewed focus on reaching populations  
most at-risk, including gay and bisexual men, 
african americans and latinos—populations  
that have been disproportionately impacted  
by hiV/aidS in the U.S.
the launch of the national hiV/aidS Strategy 
has defined roles for the private and public 
sectors to support and monitor the strategy’s 
implementation, creating new opportunities 
for leadership within hiV/aidS-related 
philanthropy—a sector that has continually 
evolved their grant making approaches to meet 
the changing needs of epidemic. 
For nearly two decades the Elton John AIDS 
Foundation (EJAF) has done just this by 
evaluating its grant making priorities within the 
context of the ever-changing hiV/aidS epidemic 
and targeting its grant awards where they will 
make the greatest impact. one of eJaF’s grant 
making priorities includes addressing hiV among 
men who have sex with men, a population 
that, according to the U.S centers for disease 
control & Prevention (cdc), accounted for 57% 
of new hiV infections in the U.S. in 2006. below 
is a spotlight on two of eJaF-USa’s paramount 
funding collaborations and innovative grant 
making initiatives that address men who have sex 
with men. 
National AIDS Fund—Challenge Grants
in 2010 eJaF awarded the national aidS Fund 
$1.3 million to support challenge Grants to its 
community Partnership network. the national 
aidS Fund targets this program to reach most 
impacted regions and demographics in the US 
while using resources most efficiently. Funds 
are focused on the most highly impacted 
populations, specifically men who have sex with 
men, injection drug users, communities of color, 
women, and those affected by incarceration; 
and the most highly impacted geographic 
areas, specifically large epicenters (i.e. d.c., 
chicago, new York city, San Francisco, los 
angeles, atlanta), the Southern U.S. and Puerto 
rico.  eJaF challenge Grants must be matched 
2:1 by local funding. typically the community 
Partnership far exceeds the match requirement 
leveraging approximately $6 million of additional 
resources each year. Moving forward this 
collaboration will make specific investments to 
spur innovation, and increase the use of evidence 
and evaluation as a means of building capacity 
and taking to scale, programs that work.    
EXAMPLES OF INNOVATIVE FUNDING
UNDERSTANDING A CHANGING EPIDEMIC 
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About the Elton John AIDS Foundation:
established in the US in 1992 and in the UK  
in 1993 by Sir elton John, eJaF is one of 
the world’s leading non-profit organizations 
supporting innovative hiV prevention programs, 
efforts to eliminate hiV/aidS-related stigma 
and discrimination, and direct care and support 
services for people living with hiV/aidS. 
together, both entities have raised over  
$220 million for worthy programs in 55  
countries around the globe since inception.  
www.ejaf.org
The Henry J. Kaiser Family Foundation— 
The Greater Than AIDS Campaign
in 2010 eJaF provided a grant of $325,000 to 
the Kaiser Family Foundation for the nationwide 
Greater than aidS campaign, to expand 
targeted messages focusing on black gay and 
bisexual men. the Greater Than AIDS movement 
responds to the aidS crisis in the United States, 
in particular the severe and disproportionate 
epidemic among black americans. through 
a national media campaign and community 
outreach, Greater than aidS aims to elevate the 
public’s knowledge and understanding of  
hiV/aidS and confront the stigma surrounding 
the disease. although national in scope, the 
effort is targeted to communities heavily 
affected by hiV/aidS. according to the cdc, 
the leading cause of hiV infection among black 
american men is sexual contact with other 
men. this project will create and disseminate 
targeted public service ads to help combat 
the debilitating stigma that undermines hiV 
prevention and treatment efforts and among gay 
and bisexual black men (with an emphasis in the 
South). this grant also helps to launch eJaF’s 
new national grant-making initiative focused 
on further addressing the rise in hiV infection 
among gay and bisexual men in the U.S. through 
this initiative, eJaF will invest over $1 million in 
grants for projects that: (1) expand community 
mobilization for the health and rights of gay men 
and (2) strengthen gay-friendly clinical and  
social services.
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FCAA was able to obtain survey data on intended use of domestic HIV/AIDS grants for 46 of the 
top 67 U.S. HIV/AIDS funders in 2009. The chart below shows both the 2008 and 2009 intended 
use of domestic funding totals for a year-to-year comparison.
Chart 11: 
Domestic Intended Use of U.S. HIV/AIDS Philanthropic Funding in 2008 and 2009
the “other” category for domestic intended use includes funding that was unspecified and funding for projects that did not fall  
under the pre-determined categories, such as: funding that fell across multiple categories and could not be broken down, 
organizational capacity building, technical assistance, fundraising events and activities, stigma reduction activities, long-term health 
systems strengthening, and strategic organizational development.
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Top U.S. HIV/AIDS funders were asked to identify the three population groups that receive the 
greatest benefit from their domestic funding. (Some funders reported more than three populations 
as their main focus, but they were asked to list only the top three target populations of their 
funding.) Chart 12 shows the percentage of the 49 total respondents that chose each category. The 
categories are not mutually exclusive.
Chart 12: 
Domestic Target Populations for U.S. HIV/AIDS Grantmaking in 2009
(by percentage of 49 top domestic funders from which target populations data were obtained)
the “other” category for domestic target populations included responses that fell outside of the pre-determined categories. Funders 
reported examples as “other” such as medical research not directed to a specific population, and all persons at risk of contracting hiv.

























Percentage of top domestic funders
HCWs: health care workers 
IDUs: injecting drug users 
MSM: Men who have sex with men 
OVC: orphans and vulnerable children 
PLWHA: People living with hiV/aidS
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Sources of HIV/AIDS Grantmaking Data
This report covers HIV/AIDS grant disbursements and commitments from all sectors of U.S. 
philanthropy, including private, family, and community foundations; public charities; corporate 
grantmaking programs (corporate foundations and direct giving programs); and major U.S.  
HIV/AIDS grantmaking charities. FCAA included data for 342 grantmaking entities in this report. 
Data were collected using a variety of sources: 1) a survey tool developed and administered by 
FCAA to funders, 2) grants databases maintained by the Foundation Center and Foundation 
Search, 3) funder websites, grants lists and 990 forms, and 4) direct communications with funders. 
FCAA believes that this multi-faceted approach arrives at a more comprehensive data set of  
HIV/AIDS funders than can be accomplished using any single data source or any single method  
of calculation.   
FCAA FUNDER SURVEy 
FCAA distributed a survey instrument that asked respondents to describe their HIV/AIDS-related 
grantmaking disbursements in 2009 (available at www.fcaaids.org). The survey was sent to several 
hundred U.S. funders in March 2010. FCAA staff distributed the survey to a pre-determined list of 
grantmaking organizations which FCAA determined were most likely to have significant levels of 
2009 HIV/AIDS grantmaking and/or were most likely to list HIV/AIDS as a priority funding issue. 
Staff conducted several rounds of follow-up to secure as much data as possible directly from funders.  
Responses to the survey were received from 67 funders, either through fully completed surveys 
or other communications with foundation staff. Approximately 94% of estimated total HIV/AIDS 
grantmaking activity is captured by surveys returned to FCAA. 
FOUNDATION CENTER AND FOUNDATION SEARCH DATABASES AND OTHER SOURCES
To capture data for which FCAA did not have survey responses, FCAA conducted further research 
of U.S. HIV/AIDS funders and 2009 HIV/AIDS grant disbursements using the Foundation Center 
and Foundation Search grants databases, as well as grantmaker websites, grants lists and 990 
forms. FCAA reviewed HIV/AIDS grantmaking totals and notable data set outliers.  
It is important to reiterate that 2009 data for the Children’s Investment Fund Foundation (US), the 
Firelight Foundation and Gilead Foundation—all likely to have been top HIV/AIDS funders that 
year—were not available as this report was being prepared, and are therefore not included.  
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AnAlysis
DEFINITION OF HIV/AIDS PHILANTHROPy
FCAA was intentionally broad in its definition and selection of U.S.-based HIV/AIDS funders by 
including the HIV/AIDS philanthropic activity of several large U.S.-based public charities, donor-
advised funds, corporate grantmaking programs, and operating foundations. While this report 
focuses only on U.S.-based funders, it also includes HIV/AIDS grants from foreign offices of U.S.-
based foundations that operate internationally, such as the Ford Foundation. 
Survey respondents were asked to distinguish as best as possible between domestic (within the 
United States and for U.S. programs) and international HIV/AIDS efforts. For domestic U.S. 
grantmaking, FCAA requested regional data based on five U.S. sub-regions, using Northeast, South, 
Midwest, West, and U.S. territories categories as defined by the U.S. Census Bureau and used by 
CDC and other federal agencies.36 For internationally focused HIV/AIDS grantmaking, FCAA 
requested data about where the grantee was located, using the following global regions as defined 
by UNAIDS:37 
Caribbean 
Anguilla, Antigua and Barbuda, Aruba, Bahamas, Barbados, Bermuda, British Virgin Islands, 
Cayman Islands, Cuba, Dominica, Dominican Republic, French Guyana, Grenada, Guadeloupe, 
Guyana, Haiti, Jamaica, Martinique, Montserrat, Netherland Antilles, Puerto Rico, St. Kitts and 
Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, Trinidad and Tobago, Turks and Caicos 
Islands, U.S. Virgin Islands 
Latin America 
Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, 
Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela 
Western and Central Europe
Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, 
Liechtenstein, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, 
United Kingdom of Great Britain and Northern Ireland, Vatican City 
Eastern Europe and Central Asia 
Armenia, Albania, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, 
Czech Republic, Estonia, Georgia, Hungary, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, 
Macedonia, Malta, Moldova, Poland, Romania, Russian Federation, Serbia and Montenegro, 
Slovakia, Slovenia, Tajikistan, Turkey, Turkmenistan, Ukraine, Uzbekistan 
36 U.S. census bureau. “census regions and divisions of the United States” online: www.census.gov
37 www.unaids.org
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West and Central Africa 
Benin, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad,  
Congo (Brazzaville), Congo (DR), Côte d’Ivoire, Equatorial Guinea, Gabon, Gambia, Ghana, 
Guinea-Bissau, Guinea (Conakry), Liberia, Mali, Mauritania, Niger, Nigeria, Sao Tome,  
Senegal, Sierra Leone, Togo
East and Southern Africa
Angola, Botswana, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Lesotho, Madagascar,  
Malawi, Mauritius, Mozambique, Namibia, Rwanda, Seychelles, Somalia, South Africa,  
Swaziland, Uganda, United Republic of Tanzania, Zambia, Zimbabwe  
North Africa and the Middle East
Afghanistan, Algeria, Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya,  
Morocco, Oman, Palestinian Territories, Qatar, Saudi Arabia, Sudan, Syria, Tunisia,  
United Arab Emirates, Yemen  
South Asia and the Pacific 
Australia, Bangladesh, Bhutan, Fiji, India, Maldives, Nepal, New Zealand, Pakistan,  
Papua New Guinea, Samoa, Sri Lanka, Timor-Leste
East Asia and South East Asia
Brunei Darussalam, Cambodia, China, Indonesia, Japan, Lao People’s Democratic Republic,  
Korea (DPR), Korea (Republic), Malaysia, Mongolia, Myanmar, Philippines, Singapore,  
Thailand, Vietnam
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FCAA also asked about the intended use of HIV/AIDS grants disbursed both inside and outside 
the United States, using the following nine categories: 
• HIV/AIDS awareness and prevention (including harm reduction);
• HIV/AIDS-related treatment and medical care (including provider and patient  
treatment information);
• HIV/AIDS-related social services (e.g., housing, employment, food, legal);
• HIV/AIDS public policy, advocacy and communications (including human rights programs);
• HIV/AIDS research (including medical, prevention and social science research); 
• Orphans and vulnerable children;
• Human resources (e.g., training, recruitment and retention of health care workers); 
• Program management and administration (e.g., core support); and
• Other
FCAA also asked funders to indentify the three population groups that benefit the most from their 
domestic and/or international funding. The tally of responses listed in this report captures the 
number of funders focusing on particular groups, not the relative share of actual funding dedicated 
to addressing these groups.  
DISBURSEMENTS VS. COMMITMENTS
FCAA uses funders’ disbursements rather than funding commitments to calculate distribution of 
total funding by geographic region, intended use and other details. The reliance on disbursement 
data for funding details harmonizes the report with other resource tracking projects. 
Disbursements are the amount of funding expended on grants/projects in a given year and 
may include funding from commitments made in prior years as well as in the current year. 
Commitments are funding budgeted for grants/projects in a given year, whether or not the funds 
were disbursed in that year. For some funders, commitments and disbursements are the same  
in a given year; for others, commitments indicate funding above or below actual disbursements in 
a year.
CALCULATIONS OF RE-GRANTING
To avoid counting the same funds twice, data in this report are adjusted to account for known 
re-granting. Re-granting refers to funds given by one FCAA-tracked grantmaker to another for 
the purposes of making HIV/AIDS-related grants. The 2009 aggregate total grantmaking for all 
funders was adjusted downward by $14,965,747 to account for known re-granting. This adjustment 
represents approximately 2% of the total estimated 2009 HIV/AIDS grant disbursements. The 
re-granting figures are estimates based on direct communications with funders following review 
of FCAA survey and Foundation Center and Foundation Search data. The true re-granting total is 
likely slightly higher than the total used for calculating the 2009 total. 
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LIMITATIONS
FCAA’s data may differ from other data on HIV/AIDS philanthropy in several ways:
1. The use of multiple data sources is the main way FCAA seeks to ensure the accuracy of  
the information presented in its report. However, such reliance also presents challenges  
in reconciling the different methodologies—each of which has its respective advantages  
and limitations—applied to obtain information about grantmaking and philanthropic  
support activity. 
2. Missing data/under-reporting: FCAA recognizes that its data for 2009 HIV/AIDS grantmaking 
are likely to have missed HIV/AIDS disbursements from some institutions for which FCAA 
had no information or incomplete or unverified data. FCAA was also unable to collect data 
from some of the philanthropic organizations that did not respond to the survey, in addition to 
institutions for which data were unavailable from the Foundation Center, Foundation Search, 
or other sources. 
 In the case of corporations, although federal law makes a corporation’s tax returns open to 
the public, businesses are not otherwise legally required to disclose details about corporate 
philanthropic giving. Thus, determining levels of corporate philanthropic efforts are 
more challenging than estimations of private foundation/public charity giving. Moreover, 
corporations are neither required nor always able to place a value on the many forms of other 
support they can and do offer, such as volunteer efforts by their employees, in-kind donations, 
cause-related marketing, and similar activities.38 Finally, philanthropic support is often not 
collected centrally within corporations and may be higher than reported in this publication.39 
3. The definition of HIV/AIDS-related philanthropy in the survey was intentionally inclusive  
and broad, in acknowledgement of the fact that such efforts often overlap with many other 
issue areas of philanthropy. Several respondents chose a restricted definition and reporting  
of HIV/AIDS-related grantmaking, excluding grants that were not wholly focused on  
HIV/AIDS efforts.
38 See also committee to encourage corporate Philanthropy, “the corporate Giving Standard: a Measurement 
Model for corporate Philanthropy,” which aims to establish methods of accounting for corporate contributions: www.
corphilanthropy.org.
39 according to the national committee for responsive Philanthropy, an estimated 50% of corporate philanthropy is 
undisclosed to the american public. national committee for responsive Philanthropy. The NCRP Quarterly, Summer 
2003, p 7.
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The data in this report represent financial contributions only from HIV/AIDS funders, in the 
form of external grants and programs. Such financial contributions can be used to conduct a trend 
analysis because they are quantifiable as monetary amounts and are measurable in a clear and 
distinct way. However, many funders contribute in other important ways that are not as easily 
quantifiable or measurable. Some examples are noted below.
PRIVATE OPERATING FOUNDATIONS
Private operating foundations are those specifically designated as such by the Internal Revenue 
Service (IRS). They use the bulk of their resources to run their own charitable programs and 
make few, if any, grants to outside organizations. In some cases, the HIV/AIDS philanthropy 
reported to FCAA includes the value of programmatic efforts and operational grantmaking, but not 
operational (internal) staff or other costs.
The Henry J. Kaiser Family Foundation is one example of a private operating foundation that is 
not able to identify and report HIV/AIDS-specific funding. Nevertheless, it is a leader in providing 
resources to support its own critical HIV/AIDS policy, media and communications programs. The 
Kaiser Daily HIV/AIDS report, HIV/AIDS fact sheets, polls, and analysis and research on policies 
and funding have served an invaluable role as leading sources of information for the field. The 
foundation also uses media to reach at-risk populations (as part of the Global Media Initiative), 
and aims to facilitate creative partnerships between advocates and policymakers to build capacity 
in HIV-affected communities.
CORPORATE PROGRAMS
Several corporations that operate HIV/AIDS programs are not willing or able to report those 
programs financially. In some cases, corporations do not centrally or specifically track HIV/AIDS 
expenditures and therefore reporting is not feasible. Also, many corporations with branch facilities 
in areas highly affected by HIV (such as in sub-Saharan Africa) support workplace programs that 
provide HIV/AIDS services to employees, sometimes extending those services to employees’ 
families or all community members. These HIV/AIDS-specific services are usually offered with 
other health services at a corporate facility’s on-site clinic. As such, quantifying the monetary 
value of specific HIV/AIDS services for a corporation with facilities in several countries is very 
difficult and is usually not available.
In addition, other forms of support—such as volunteer efforts by corporate employees, matching 
donations programs, in-kind donations, cause-related marketing, and donations of technical 
assistance—are not always able to be valued monetarily or tracked as such. They are nonetheless 
valuable resources offered by corporations, especially those that can leverage other investments or 
build the capacity of communities to operate their own programs and services.
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IN-KIND DONATIONS
FCAA offers funders the option of reporting donations of goods and services that are not or cannot 
be valued monetarily. Some reported examples are noted below, illustrating the diversity  
of support:
• Abbott and Abbott Fund: Provision of the Determine brand of rapid diagnostic tests for 
Abbott’s prevention of vertical transmission program
• Bristol-Myers Squibb Foundation and Bristol-Myers Squibb Company: In 2009, grantees 
and partners from Bristol-Myers Squibb’s Secure the Future program continued to provide 
technical support to organizations, governments and communities in Africa on governance, 
financial management, food security and income generating activities. As part of its Technical 
Assistance Program, Secure the Future deploys a faculty of more than 50 experienced 
managers and implementers to work alongside community-based HIV/AIDS organizations and 
provide highly customized assistance. The faculty comprises program managers; field workers; 
researchers; practitioners in the care of orphans and other vulnerable children, community 
mobilization and capacity building; and experts in the fields of monitoring and evaluation. In 
addition to the Technical Assistance Program, Bristol-Myers Squibb also provides HIV/AIDS 
medicines at no profit pricing in least developed countries.
• Children Affected By AIDS Foundation: Toy distribution for children impacted by HIV in 
the United States, with an estimated value of $250,000; and special event tickets for children 
and families in the U.S., with a value of $25,000.
• Design Industries Foundation Fighting AIDS (DIFFA): Home furnishings valued at 
$150,000, decorative accessories valued at $90,000, gift industry items valued at $75,000, travel 
vouchers valued at $25,000, and clothing valued at $50,000.
• M•A•C AIDS Fund and M•A•C Cosmetics: Donation of approximately $19,566.50  
(retail value: $216,860.00) in cosmetics to HIV/AIDS organizations in North America. M•A•C 
makeup artists also participate in the M•A•C Good Spirits program, where they volunteer 
their time to teach men and women with HIV/AIDS simple makeup techniques to help them 
enhance their appearance and minimize problems resulting from the illness or medication 
regimens. The program aims to encourage those living with HIV/AIDS to be active in 
promoting their own health and well-being. In 2009, 51 Good Spirits events were held in North 
America providing more than $1 million in donated services and staff time to over 3,202 people 
affected with HIV/AIDS. 
• Pfizer Inc and Pfizer Foundation: As part of its Global Health Fellows Program, highly skilled 
Pfizer employees such as physicians, nurses, lab technicians, marketing managers, financial 
administrators and health educators have visited 39 different countries to work with and 
transfer skills to local partners and NGOs and improve health care. Assignments have ranged 
from helping hospitals improve data collection and information technology to providing 
clinical training for health care workers and supporting the expansion of services of local 
clinics. Pfizer also provides donations of the medicine Diflucan (fluconazole) from Pfizer Inc 
to governments and NGOs in developing countries, and materials to support patient education 
and health care worker training. 
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FUNDERS WITH A BROADER FOCUS
In some cases, funders choose to support projects across broad focus areas, such as health  
systems strengthening or sexual and reproductive health, where funding for HIV/AIDS would 
only be a part of a grant or project. FCAA asks funders to report a project or grant if a significant 
aspect is focused on HIV/AIDS; however, some funders may not be able to separately quantify 
specific HIV/AIDS funding. Of course, all HIV/AIDS interventions are important and should be 
encouraged, including the more broad approaches, even though they are difficult to track.
OTHER SOURCES OF SUPPORT
Community programs, research institutions, hospitals, clinics, counseling centers, churches, 
homeless shelters, orphanages, private individual donors, and anonymous donors all represent 
other sources of HIV/AIDS funding, goods, and services that are difficult to identify and/or 
quantify. Even so, they are highly valuable contributions.
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